Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Multiple Sclerosis, Sarcopenia and Respiration
This record announces the completion of a Uskudar University–sponsored clinical trial on multiple sclerosis with assessments of sarcopenia a…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis
A clinical trial update announcing development of a novel functional eye-tracking software for people with multiple sclerosis, currently rec…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Safety of Bryostatin in Patients With MS [Phase 1]
A Phase 1 safety trial evaluating Bryostatin in people with multiple sclerosis was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Evaluation of Interoception, Fatigue, and Upper and Lower Extremity Functional Capacity in Multiple Sclerosis Patients With Good and Poor Sleep Quality
This completed clinical trial evaluated how interoception, fatigue, and upper- and lower-extremity functional capacity relate to sleep quali…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS) [Phase 2]
Phase 2 clinical trial evaluating pharmacokinetics and safety of subcutaneous ublituximab in multiple sclerosis. The study compares injectio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: The Effect of Remotely Delivered Pilates on Physical , and Psychological Outcomes in Individuals With Multiple Sclerosis [NA]
This ClinicalTrials.gov entry describes a study evaluating remotely delivered Pilates for individuals with Multiple Sclerosis, measuring phy…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Clinical Efficacy of a telerehabilItation Protocol, for the Improvement of Balance in Degenerative Neurological Diseases [NA]
A clinical trial update reports on the efficacy of a telerehabilitation protocol to improve balance in degenerative neurological diseases, i…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)
A recruiting study evaluating the effects of ocrelizumab on neurofilament light chain levels and participant satisfaction in people with Mul…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis [Phase 3]
This document describes a Phase 3 pediatric clinical trial evaluating the efficacy and safety of ofatumumab and siponimod compared with fing…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Effect of Low Histamine-Based Modified Mediterranean Diet in Multiple Sclerosis [NA]
Clinical trial update confirming the completion of a study assessing the impact of a low histamine-based modified Mediterranean diet on rela…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: VR and Orthoses for Rehabilitation in Multiple Sclerosis [NA]
A clinical trial evaluating virtual reality and orthoses-based rehabilitation for people with multiple sclerosis is currently recruiting in …
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Digital Therapeutic to Improve Insomnia in Multiple Sclerosis: A Randomized Controlled Trial. [NA]
A randomized controlled trial is evaluating a digital therapeutic to improve insomnia in people with multiple sclerosis; the study is curren…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Effects of Mat and Reformer Pilates in Multiple Sclerosis [NA]
A Gazi University clinical trial evaluating the effects of Mat and Reformer Pilates in people with Multiple Sclerosis has completed.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics (processing by the body) of intravenous and subcutaneous RO7121932 in pa…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS) [Phase 2]
This Phase 2 study is evaluating the bioequivalence of two subcutaneous formulations of ocrelizumab in people with multiple sclerosis; recru…
-
CLINICAL_TRIALS withdrawal · 2026-03-30Clinical Trial Update: Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years (STOP-I-SEP) [Phase 3]
Phase 3 clinical trial evaluating withdrawal of disease-modifying therapies in inactive secondary progressive multiple sclerosis patients ov…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues [EARLY_Phase 1]
This early-phase trial of liraglutide in high-risk obese participants with cognitive concerns related to Multiple Sclerosis or Long COVID ha…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Skeletal Muscle Aging and Responsiveness in Aged People With MS [NA]
A clinical trial sponsored by the Oklahoma Medical Research Foundation is recruiting to study skeletal muscle aging and responsiveness in ol…
-
CLINICAL_TRIALS withdrawal · 2026-03-30Clinical Trial Update: This is an Open-Label Study to Assess the Safety and Efficacy of GC012F in Patients With Multiple Sclerosis [EARLY_Phase 1]
An open-label early Phase 1 trial evaluating GC012F for safety and efficacy in patients with multiple sclerosis has been withdrawn.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis [Phase 4]
A Phase 4 clinical trial is evaluating the concentration of the anti‑MS antibody ofatumumab in the breast milk of lactating women with relap…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease Activity [NA]
A clinical trial update describes monthly monitoring of plasma neurofilament light (NfL) in patients with treated relapsing-remitting multip…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Comparison of Gait Metrics in Patients With Stroke, Traumatic Brain Injury, and Multiple Sclerosis [NA]
Clinical trial update noting a gait metrics study comparing stroke, traumatic brain injury, and multiple sclerosis is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis [Phase 4]
Phase 4 clinical trial update on ocrelizumab in relapsing-remitting multiple sclerosis, describing its effects on immune cells in lymph node…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: A Self-management Program to Prevent Falls in People With Multiple Sclerosis [NA]
A completed clinical trial evaluated a self-management program aimed at preventing falls in people with multiple sclerosis.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity [Phase 2]
Phase 2 clinical trial evaluating the efficacy, safety and tolerability of BMS-986368 in participants with multiple sclerosis-associated spa…